Ampio Pharmaceuticals Inc (NYSE MKT LLC:AMPE)
During the Trading Day
| 6.03 |  -0.12 / -1.95% |
Data as of 4:02pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 6.03 |  0.00 / 0.00% |
Volume: 8.6K |
Latest AMPE News | Press Releases
| Buying the Dips and Selling the Rips Is the New Norm for This Market Jul 29 / TheStreet.com | How Many More 100-Point-Swing Days on the DJIA Can You Take? Jul 28 / TheStreet.com |
Today’s Trading
| Previous close | 6.15 |
| Today’s open | 6.28 |
| Day’s range | 5.91 - 6.28 |
| Volume | 664,192 |
| Average volume (3 months) | 678,259 |
| Market cap | $319.3M |
| Dividend yield | -- |
Data as of 4:02pm ET, 07/31/2014
Growth & Valuation
| Earnings growth (last year) | -85.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 5,460.76 |
| Price/Book | 7.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SVASinovac Biotech Ltd | -0.09 | -1.60% |
| TGTXTG Therapeutics Inc | -0.26 | -3.18% |
| ZIOPZIOPHARM Oncology In... | -0.13 | -3.99% |
| RPRXRepros Therapeutics ... | -0.35 | -2.44% |
Data as of 4:00pm ET, 07/31/2014
Financials
| Next reporting date | September 3, 2014 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $50.0K |
| Annual profit (last year) | -$24.0M |
| Net profit margin | -48,017.12% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Operating Officer Joshua R. Disbrow |
Corporate headquarters Greenwood Village, Colorado |
Forecasts
.
